Safety of Russian-Backbone Trivalent, Live Attenuated Seasonal Influenza Vaccine in Healthy Subjects: Open-Label, Non-randomized Phase 4 Study
ConclusionsThe data from the study adds to the existing safety database of Nasovac-S.RegistryClinical Trials Registry of India (CTRI/2015/08/006074).
Source: Drug Safety - Category: Drugs & Pharmacology Source Type: research
More News: Databases & Libraries | Drugs & Pharmacology | India Health | Influenza | Influenza Vaccine | Russia Health | Study | Vaccines